DK0763055T3 - Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf - Google Patents

Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0763055T3
DK0763055T3 DK95917216T DK95917216T DK0763055T3 DK 0763055 T3 DK0763055 T3 DK 0763055T3 DK 95917216 T DK95917216 T DK 95917216T DK 95917216 T DK95917216 T DK 95917216T DK 0763055 T3 DK0763055 T3 DK 0763055T3
Authority
DK
Denmark
Prior art keywords
elastase
pct
inhibitors
perflouralkyl
preparation
Prior art date
Application number
DK95917216T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Michael R Angelastro
Timothy T Curran
William A Metz Jr
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0763055T3 publication Critical patent/DK0763055T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95917216T 1994-06-02 1995-05-01 Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf DK0763055T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25285794A 1994-06-02 1994-06-02
US32752094A 1994-10-20 1994-10-20
PCT/US1995/005363 WO1995033762A1 (en) 1994-06-02 1995-05-01 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same

Publications (1)

Publication Number Publication Date
DK0763055T3 true DK0763055T3 (da) 2000-05-08

Family

ID=26942742

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95917216T DK0763055T3 (da) 1994-06-02 1995-05-01 Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
US (1) US6008196A (ja)
EP (1) EP0763055B1 (ja)
JP (1) JP3721538B2 (ja)
KR (1) KR100366328B1 (ja)
CN (1) CN1152048C (ja)
AT (1) ATE186305T1 (ja)
AU (1) AU690986B2 (ja)
CA (1) CA2189526C (ja)
DE (1) DE69513167T2 (ja)
DK (1) DK0763055T3 (ja)
ES (1) ES2137509T3 (ja)
FI (1) FI964789A (ja)
GR (1) GR3032294T3 (ja)
HU (1) HU221311B1 (ja)
IL (1) IL113941A (ja)
NO (1) NO316706B1 (ja)
NZ (1) NZ284766A (ja)
TW (1) TW376388B (ja)
WO (1) WO1995033762A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof
CA2189526C (en) * 1994-06-02 2001-02-27 William A. Metz, Jr. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
WO1998024806A2 (en) * 1996-12-06 1998-06-11 Cortech, Inc. Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
EP1089752A4 (en) 1998-06-03 2002-01-02 Cortech Inc ALPHA-KETO OXADIAZOLE AS A SERINE PROTEASE INHIBITOR
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
KR20110017465A (ko) * 2002-04-25 2011-02-21 더 스크립스 리서치 인스티튜트 폐질환 증상의 치료 및 예방
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
DK1941867T3 (da) * 2002-06-07 2012-01-02 Dyax Corp Polypeptid med modificeret Kunitz domæne
AU2004268144A1 (en) * 2003-08-29 2005-03-10 Dyax Corp. Modified protease inhibitors
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
PT1981519T (pt) * 2005-12-29 2018-02-23 Dyax Corp Inibição de protéases
JP2010536870A (ja) * 2007-08-21 2010-12-02 ジェンザイム・コーポレーション カリクレイン阻害剤を用いた治療
WO2010080833A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
CA3168591A1 (en) 2010-01-06 2011-07-14 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
KR102502293B1 (ko) 2011-01-06 2023-02-21 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
IL295414A (en) 2014-03-27 2022-10-01 Takeda Pharmaceuticals Co Compositions and methods for treating macular edema as a result of diabetes
NZ744233A (en) 2015-12-11 2023-11-24 Takeda Pharmaceuticals Co Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP4031138A1 (en) 2019-09-17 2022-07-27 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
MX2022012942A (es) 2020-04-16 2023-01-11 Mereo Biopharma 4 Ltd Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina.
IL312002A (en) 2021-10-20 2024-06-01 Mereo Biopharma 4 Ltd Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
CA1267499A (en) * 1983-07-12 1990-04-03 Cedric H. Hassall Peptide amides and aldehydes
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
EP0204571B1 (en) * 1985-06-07 1992-01-22 Ici Americas Inc. Selected difluoro derivatives
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
US4935405A (en) * 1986-10-31 1990-06-19 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
EP0318318A1 (en) * 1987-11-27 1989-05-31 Sensititre Limited Urine assay process and kit
US5162307A (en) * 1988-09-09 1992-11-10 Board Of Trustees Of The University Of Kentucky Polymer bound elastase inhibitors
EP0371179A1 (en) * 1988-10-28 1990-06-06 Merrell Dow Pharmaceuticals Inc. Novel analogs of peptidase substrates
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
WO1991013904A1 (en) * 1990-03-05 1991-09-19 Cephalon, Inc. Chymotrypsin-like proteases and their inhibitors
CA2056453A1 (en) * 1990-03-30 1991-10-01 Koji Kobayashi 4h-3, 1-benzoxazin-4-one derivative
EP0564561A4 (en) * 1990-12-28 1994-08-10 Georgia Tech Res Inst Peptides ketoamides, ketoacids, and ketoesters
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
AU1581692A (en) * 1991-03-01 1992-10-06 Protein Engineering Corporation Inhibitors of human neutrophil elastase and human cathepsin g
EP0587799B1 (en) * 1991-05-23 1999-07-07 Merrell Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
CA2171882C (en) * 1993-10-01 2001-12-04 Barbara Cordell Inhibitors of .beta.-amyloid protein production
NZ285565A (en) * 1994-06-02 1998-08-26 Hoechst Marion Roussel Inc Short synthetic peptide elastase inhibitors
CA2189526C (en) * 1994-06-02 2001-02-27 William A. Metz, Jr. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof

Also Published As

Publication number Publication date
NO316706B1 (no) 2004-04-13
US6008196A (en) 1999-12-28
CN1149876A (zh) 1997-05-14
JPH10501529A (ja) 1998-02-10
AU2400095A (en) 1996-01-04
MX9606031A (es) 1998-05-31
EP0763055B1 (en) 1999-11-03
HUT75318A (en) 1997-05-28
KR100366328B1 (ko) 2003-03-06
CN1152048C (zh) 2004-06-02
FI964789A0 (fi) 1996-11-29
HU9603311D0 (en) 1997-01-28
EP0763055A1 (en) 1997-03-19
AU690986B2 (en) 1998-05-07
HU221311B1 (en) 2002-09-28
DE69513167D1 (de) 1999-12-09
DE69513167T2 (de) 2000-06-15
IL113941A (en) 2000-02-17
TW376388B (en) 1999-12-11
GR3032294T3 (en) 2000-04-27
NO965098L (no) 1997-01-31
NO965098D0 (no) 1996-11-29
WO1995033762A1 (en) 1995-12-14
IL113941A0 (en) 1995-08-31
ATE186305T1 (de) 1999-11-15
NZ284766A (en) 1998-06-26
CA2189526C (en) 2001-02-27
ES2137509T3 (es) 1999-12-16
JP3721538B2 (ja) 2005-11-30
CA2189526A1 (en) 1995-12-14
FI964789A (fi) 1996-11-29

Similar Documents

Publication Publication Date Title
DK0763055T3 (da) Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
SE9604793D0 (sv) New polymorphs
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
DE69533876D1 (de) Zusammensetzung für die gentherapeutische Behandlung von Koronar-Arterienerkrankungen.
BR9808923A (pt) Composto, e, processo para fazer o mesmo
TR200200278T2 (tr) Kalsilitik bileşimler
DE59900222D1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
NO974687D0 (no) Kondenserte <beta>-carboliner
ATE312611T1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen